Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Frazier Lifesciences Acquisition Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
12/01/2022 SC 13G/A Flynn James E reports a 0% stake in Frazier Lifesciences Acquisition Corp.
11/25/2022 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 0% stake in Frazier Lifesciences Acquisition Corporation
11/23/2022 8-K Appointed a new director
Docs: "Amended and Restated Memorandum and Articles of Association of the Surviving Company",
"Certificate of Incorporation of Frazier Lifesciences Acquisition Corporation",
"Bylaws of Frazier Lifesciences Acquisition Corporation",
"Warrant Assignment, Assumption and Amendment Agreement, between Continental Stock Transfer & Trust Company, NewAmsterdam Pharma Company B.V. and Frazier Lifesciences Acquisition Corporation",
"NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Patients"
11/23/2022 SC 13D/A Frazier Lifesciences Sponsor LLC reports a 0% stake in Frazier Lifesciences Acquisition Corporation
11/22/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/22/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/22/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/16/2022 425 Form 425 - Prospectuses and communications, business combinations:
11/15/2022 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Frazier Lifesciences Acquisition Corporation shareholders approve business combination with NewAmsterdam Pharma Holding B.V. Menlo Park, Calif."
11/14/2022 SC 13G Flynn James E reports a 17.3% stake in Frazier Lifesciences Acquisition Corp.
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
10/18/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
10/17/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/13/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/11/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/05/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/05/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/29/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/28/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/23/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/22/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/21/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/20/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/20/2022 SC 13D/A Frazier Lifesciences Sponsor LLC reports a 10.5% stake in Frazier Lifesciences Acquisition Corporation
08/29/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/24/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/24/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/23/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/19/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/17/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/16/2022 425 Form 425 - Prospectuses and communications, business combinations:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy